Hearing Loss Cure - Search News

FDA approves 1st gene therapy for genetic hearing loss

Regeneron to offer hearing-loss therapy for free after FDA nod

Regeneron Pharmaceuticals Inc. will offer a gene therapy that restored hearing for a small number of profoundly deaf children at no cost after US regulators approved the treatment.

· 20h

FDA approves Regeneron’s hearing loss gene therapy

· 19h

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

· 3h

Regeneron FDA approval: gene therapy for inherited deafness free

The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and Regeneron said it will make the treatment available at no cost to eligible patients...

STAT · 1d

Gene therapy trial for deafness adds evidence to drug’s efficacy

Becker's Hospital Review · 1d

Gene therapy restores hearing to 90% of patients in deafness study

3hon MSN

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

18hon MSN

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a clinical trial who were born without hearing.